Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

British Journal of Cancer

Volumn 105, Issue 10, 2011, Pages 1503-1511

  Broadhead, M L ^a,b   Dass, C R ^c   Choong, P F M ^a,b,d  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIA UNIVERSITY   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

orthotopic model; osteosarcoma; PEDF

Indexed keywords

COLLAGEN TYPE 1; PIGMENT EPITHELIUM DERIVED FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SAFETY; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIMARY TUMOR; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SYSTEMIC THERAPY; THERAPY DELAY; TUMOR VOLUME;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EYE PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; NERVE GROWTH FACTORS; OSTEOSARCOMA; SERPINS;

EID: 80755128482     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.410     Document Type: Article

References (25)

1. Broadhead ML, Clark JC, Choong PF, Dass CR (2010) Making gene therapy for osteosarcoma a reality. Expert Rev Anticancer Ther 10(4): 477-480
2. Broadhead ML, Dass CR, Choong PF (2009) In vitro and in vivo biological activity of PEDF against a range of tumours. Expert Opin Ther Targets 13(12): 1429-1438
3. Dass CR, Contreras KG, Dunstan DE, Choong PF (2007) Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 28(19): 3026-3033 (Pubitemid 46560874)
4. Dass CR, Ek ET, Contreras KG, Choong PF (2006) A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis 23(7-8): 367-380 (Pubitemid 46197119)
5. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285(5425): 245-248 (Pubitemid 29329995)
6. Ek ETH, Dass CR, Contreras KG, Choong PFM (2007a) Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumour activities of pigment epithelium-derived factor. Clin Exp Metastasis 24(2): 93-106 (Pubitemid 46669247)
7. Ek ETH, Dass CR, Contreras KG, Choong PFM (2007b) Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther 14(7): 616-626 (Pubitemid 46912035)
8. Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y (2004) Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11(5): 325-332 (Pubitemid 38586088)
9. Guise TA, O'Keefe R, Randall RL, Terek RM (2009) Molecular biology and therapeutics in musculoskeletal oncology. J Bone Joint Surg Am 91(3): 724-732
10. Kozaki K, Miyaishi O, Koiwai O, Yasui Y, Kashiwai A, Nishikawa Y, Shimizu S, Saga S (1998) Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells. J Biol Chem 273(24): 15125-15130 (Pubitemid 28272810)
11. Kumar V, Abbas A, Fausto N (2005) Robbins and Cotran Pathologic Basis of Disease, 7th edn, Elsevier Saunders: Philadelphia, PA, USA
12. Matsumoto K, Ishikawa H, Nishimura D, Hamasaki K, Nakao K, Eguchi K (2004) Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 40(1): 252-259 (Pubitemid 38868944)
13. Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Inoue H (2009) Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metabol Res Rev 25(1): 52-56
14. Petersen SV, Valnickova Z, Enghild JJ (2003) Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem J 374(Part 1): 199-206 (Pubitemid 37046944)
15. Quan GM, Ojaimi J, Nadesapillai AP, Zhou H, Choong PF (2002) Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. Pathobiology 70(6): 361-367 (Pubitemid 36829012)
16. Sabater M, Moreno-Navarrete JM, Ortega FJ, Pardo G, Salvador J, Ricart W, Fruhbeck G, Fernandez-Real JM (2010) Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metabol 95(10): 4720-4728
17. Sogawa K, Kodera Y, Satoh M, Kawashima Y, Umemura H, Maruyama K, Takizawa H, Yokosuka O, Nomura F (2011) Increased serum levels of pigment epithelium-derived factor by excessive alcohol consumption-detection and identification by a three-step serum proteome analysis. Alcohol Clin Exp Res 35(2): 211-217
18. Stellmach V, Crawford SE, Zhou W, Bouck N (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci USA 98(5): 2593-2597 (Pubitemid 32209527)
19. Ta HT, Dass CR, Larson I, Choong PF, Dunstan DE (2009a) A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. Biomaterials 30(27): 4815-4823
20. Ta HT, Dass CR, Larson I, Choong PF, Dunstan DE (2009b) A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials 30(21): 3605-3613
21. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T (2005) Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77(25): 3231-3241 (Pubitemid 41433323)
22. Tan ML, Friedhuber AM, Dunstan DE, Choong PF, Dass CR (2010) The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model. Biomaterials 31(3): 541-551
23. Tombran-Tink J, Johnson LV (1989) Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 30(8): 1700-1707 (Pubitemid 19214990)
24. Wiercinska-Drapalo A, Jaroszewicz J, Parfieniuk A, Lapinski TW, Rogalska M, Prokopowicz D (2007) Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity. Regul Pept 140(1-2): 1-4 (Pubitemid 46275052)
25. Yang S, Li Q, Zhong L, Song Y, Tian B, Cheng Q, Qing H, Xia W, Luo M, Mei M (2011) Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. J Clin Endocrinol Metabol 96(3): 831-836